phosphoserine has been researched along with lithium chloride in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hardt, SE; Katus, HA; Sadoshima, J; Tomita, H | 1 |
Ben-Ze'ev, A; Levina, E; Oren, M | 1 |
Boswell, S; Davis, LL; Friedman, AB; Jope, RS; Li, X; May, RS; Wang, L; Zhu, W | 1 |
Choi, SE; Jang, HJ; Kang, Y; Kim, DJ; Kim, HE; Kim, HJ; Kim, HS; Lee, KW; Shin, HC | 1 |
Beurel, E; Jope, RS; Song, L | 1 |
Abdul, AR; Gary, RK; Gorjala, P; Mudireddy, SR | 1 |
Chen, Q; Chu, J; Han, L; Qu, N; Tian, Q; Wang, JZ; Wang, L; Xu, JX; Zhang, Q; Zhang, T; Zhou, XY | 1 |
Fan, X; Feng, Y; Gao, X; He, QY; Liu, L; Liu, X; Wei, J; Xiong, H; Xu, J; Zhang, G | 1 |
8 other study(ies) available for phosphoserine and lithium chloride
Article | Year |
---|---|
Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Topics: Adenoviridae; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Eukaryotic Initiation Factor-2B; Gene Expression Regulation; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Ventricles; Hypertrophy; Isoproterenol; Lithium Chloride; Male; Myocardial Infarction; Myocytes, Cardiac; Myosin Heavy Chains; Peptide Chain Initiation, Translational; Phosphoserine; Propranolol; Protein Processing, Post-Translational; Rats; Rats, Wistar; Recombinant Fusion Proteins; Transduction, Genetic; Ventricular Remodeling | 2004 |
Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics.
Topics: Axin Protein; beta Catenin; Casein Kinases; Cells, Cultured; Cytoskeletal Proteins; Detergents; Enzyme Inhibitors; Gene Expression Regulation; Genes, p53; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Chloride; Macromolecular Substances; Neoplasm Proteins; Octoxynol; Phosphorylation; Phosphoserine; Protein Kinases; Protein Processing, Post-Translational; Protein Structure, Tertiary; Protein Transport; Recombinant Fusion Proteins; Repressor Proteins; Solubility; Subcellular Fractions; Trans-Activators; Transfection; Tumor Suppressor Protein p53 | 2004 |
Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Brain; Cytoskeletal Proteins; Female; Humans; In Vitro Techniques; Lithium Chloride; Male; Middle Aged; Monocytes; Neuronal Plasticity; Nuclear Proteins; Phosphorylation; Phosphoserine; Signal Transduction | 2007 |
Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis.
Topics: Adenoviridae; Anthracenes; Apoptosis; Caspase 3; Cell Cycle; Cells, Cultured; Cytosol; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Fumonisins; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Indoles; Lithium Chloride; Maleimides; Mitochondria; Palmitates; Phosphorylation; Phosphoserine; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; Pyridines; Thiadiazoles; Transduction, Genetic; Umbilical Veins | 2007 |
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.
Topics: Amino Acid Substitution; Animals; Antidepressive Agents; Cerebral Cortex; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Electroshock; Gene Knock-In Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Helplessness, Learned; Hippocampus; Ketamine; Lithium Chloride; Mice; Nerve Tissue Proteins; Phosphorylation; Phosphoserine; Point Mutation; Protein Processing, Post-Translational | 2011 |
Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium.
Topics: Beryllium; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Fibroblasts; Fluorescence Resonance Energy Transfer; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Chloride; Phosphorylation; Phosphoserine; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |
Combination of PPT with LiCl Treatment Prevented Bilateral Ovariectomy-Induced Hippocampal-Dependent Cognition Deficit in Rats.
Topics: Animals; Cell Nucleus; Cognition Disorders; Estrogen Receptor alpha; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Lithium Chloride; Maze Learning; Ovariectomy; Phenols; Phosphorylation; Phosphoserine; Pyrazoles; Rats, Sprague-Dawley; Spatial Memory; Up-Regulation | 2016 |
Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation.
Topics: Acetylation; Animals; Cell Differentiation; Cell Nucleus; Cytoplasm; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HEK293 Cells; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Lithium Chloride; Male; Mice; Models, Biological; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphoserine; Protein Binding; Protein Transport; Proto-Oncogene Proteins c-akt; RANK Ligand; RAW 264.7 Cells; Tubulin | 2015 |